International Journal of
Reproductive Biomedicine
Wed, May 13, 2026
[Archive]
Volume 24, Issue 3 (March 2026)
IJRM 2026, 24(3): 209-218 |
Back to browse issues page
Ethics code: IR.SBMU.RETECH.REC.1404.033
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini S, Salehpour S, Amiresmaili N, Meshkat M, Karimi F. Serum anti-Müllerian hormone and ovarian stimulation parameters in women with polycystic ovary syndrome undergoing assisted reproductive technology: A cross-sectional study. IJRM 2026; 24 (3) :209-218
URL: http://ijrm.ir/article-1-3650-en.html
URL: http://ijrm.ir/article-1-3650-en.html
1- Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Reproductive Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
3- Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ,dr.karimi@sbmu.ac.ir
2- Department of Reproductive Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
3- Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ,
Abstract: (2 Views)
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder and a major cause of anovulatory infertility. Serum anti-Müllerian hormone (AMH), a marker of ovarian reserve, is often elevated in PCOS. However, its predictive value for assisted reproductive technology (ART) outcomes remains unclear due to nonlinear associations.
Objective: This study aimed to evaluate the relationship between serum AMH levels and ART outcomes in women with PCOS undergoing in vitro fertilization or intracytoplasmic sperm injection.
Materials and Methods: In this cross-sectional study, clinical and laboratory data of 204 infertile women with PCOS who underwent ART cycles between March 2023 and March 2025 at Taleghani hospital, Tehran, Iran, were extracted from their medical records. After excluding 32 cases, AMH of 172 women were assessed both continuously and categorically (< 2.5, 2.5-6.5, > 6.5 ng/mL).
Results: Serum AMH was inversely correlated with gonadotropin dose (r = -0.39) and stimulation days (r = -0.98) and positively correlated with metaphase II oocyte count (r = 0.64) and embryo formation (r = 0.59) (p < 0.0001 for all). Multivariable regression analysis confirmed a nonlinear, inverted-U relationship between AMH and these outcomes, with the most favorable ART. Results observed in women with mid-range AMH levels (2.5-6.5 ng/mL). In addition, outcome measures differed significantly across the 3 AMH categories.
Conclusion: AMH is a robust yet nonlinear predictor of ART response in PCOS. Mid-range levels produce the best outcomes. Stratifying by AMH may enhance personalized protocols and ART effectiveness.
Objective: This study aimed to evaluate the relationship between serum AMH levels and ART outcomes in women with PCOS undergoing in vitro fertilization or intracytoplasmic sperm injection.
Materials and Methods: In this cross-sectional study, clinical and laboratory data of 204 infertile women with PCOS who underwent ART cycles between March 2023 and March 2025 at Taleghani hospital, Tehran, Iran, were extracted from their medical records. After excluding 32 cases, AMH of 172 women were assessed both continuously and categorically (< 2.5, 2.5-6.5, > 6.5 ng/mL).
Results: Serum AMH was inversely correlated with gonadotropin dose (r = -0.39) and stimulation days (r = -0.98) and positively correlated with metaphase II oocyte count (r = 0.64) and embryo formation (r = 0.59) (p < 0.0001 for all). Multivariable regression analysis confirmed a nonlinear, inverted-U relationship between AMH and these outcomes, with the most favorable ART. Results observed in women with mid-range AMH levels (2.5-6.5 ng/mL). In addition, outcome measures differed significantly across the 3 AMH categories.
Conclusion: AMH is a robust yet nonlinear predictor of ART response in PCOS. Mid-range levels produce the best outcomes. Stratifying by AMH may enhance personalized protocols and ART effectiveness.
Keywords: Anti-Mullerian hormone, Polycystic ovary syndrome, In vitro fertilization, Oocytes, Assisted reproductive techniques.
Type of Study: Original Article |
Subject:
Fertility & Infertility
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
